[
  {
    "date": "2023-12-30",
    "symbol": "ANTX",
    "period": "FY",
    "netincomeloss": -64732000,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "entityregistrantname": "AN2 Therapeutics, Inc.",
    "entitycentralindexkey": 1880438,
    "entityfilenumber": "001-41331",
    "entitytaxidentificationnumber": "82-0606654",
    "entityincorporationstatecountrycode": "DE",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "1800 El Camino Real",
    "entityaddressaddressline2": "Suite D",
    "entityaddresscityortown": "Menlo Park",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94027,
    "cityareacode": 650,
    "localphonenumber": "331-9090",
    "security12btitle": "Common Stock",
    "tradingsymbol": "ANTX",
    "securityexchangename": "NASDAQ",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "San Jose, California",
    "auditorfirmid": 238,
    "cashandcashequivalentsatcarryingvalue": 15647000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 91648000,
    "prepaidexpenseandotherassetscurrent": 3212000,
    "assetscurrent": 110507000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 27194000,
    "otherassetsnoncurrent": 1043000,
    "assets": 138744000,
    "accountspayablecurrent": 2676000,
    "employeerelatedliabilitiescurrent": 4018000,
    "accruedliabilitiescurrent": 6681000,
    "otherliabilitiescurrent": 666000,
    "optionssubjecttorepurchaseshortterm": 2000,
    "liabilitiescurrent": 14043000,
    "liabilities": 14043000,
    "additionalpaidincapital": 278881000,
    "accumulatedothercomprehensiveincomelossnetoftax": 275000,
    "retainedearningsaccumulateddeficit": -154455000,
    "stockholdersequity": 124701000,
    "liabilitiesandstockholdersequity": 138744000,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 29741445,
    "commonstocksharesoutstanding": 29741445,
    "researchanddevelopmentexpense": 54871000,
    "generalandadministrativeexpense": 14764000,
    "operatingexpenses": 69635000,
    "operatingincomeloss": -69635000,
    "othernonoperatingincomeexpense": 4903000,
    "netincomelossavailabletocommonstockholdersbasic": -64732000,
    "earningspersharebasic": -2.74,
    "earningspersharediluted": -2.74,
    "weightedaveragenumberofsharesoutstandingbasic": 23600107,
    "weightedaveragenumberofdilutedsharesoutstanding": 23600107,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 649000,
    "comprehensiveincomenetoftax": -64083000,
    "sharesoutstanding": 29741445,
    "stockissuedduringperiodvaluenewissues": 19050000,
    "stockissuedduringperiodsharesnewissues": 2502000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 366000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 44009,
    "stockissuedduringperiodvaluestockoptionsexercised": 99000,
    "stockissuedduringperiodsharesstockoptionsexercised": 15000,
    "vestingofearlyexercisedstockoptions": 6000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8412000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 649000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 900000,
    "profitloss": -64732000,
    "sharebasedcompensation": 8412000,
    "noncashoperatingleaseexpense": 53000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2855000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1026000,
    "increasedecreaseinaccountspayable": 553000,
    "increasedecreaseinaccruedcompensation": 1850000,
    "increasedecreaseinaccruedliabilities": 3844000,
    "increasedecreaseinoperatingleaseliability": -53000,
    "increasedecreaseinothercurrentliabilities": 666000,
    "netcashprovidedbyusedinoperatingactivities": -53288000,
    "paymentstoacquireinvestments": 132178000,
    "proceedsfromsalematurityandcollectionsofinvestments": 88900000,
    "netcashprovidedbyusedininvestingactivities": -43278000,
    "proceedsfromissuanceofcommonstockfromtheunderwrittenofferingnetofcommissionsandofferingexpenses": 65479000,
    "proceedsfromissuanceofcommonstockfromatthemarketofferingnetofcommissionsandofferingexpenses": 19050000,
    "proceedsfromissuanceofcommonstock": 366000,
    "proceedsfromstockoptionsexercised": 99000,
    "netcashprovidedbyusedinfinancingactivities": 84994000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -11572000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 15647000,
    "saleofstocknumberofsharesissuedintransaction": 2502000,
    "cashcashequivalentsshortterminvestmentsandlongterminvestment": 134500000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "stockholdersequitynotestocksplit": "shares of common stock and then existing redeemable convertible preferred stock and per share amounts have been adjusted on a retroactive basis to reflect our 2.352936-for-1 forward stock split",
    "investments": 118800000,
    "debtsecuritiesavailableforsaleunrealizedgainloss": 600000,
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2023-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "availableforsaledebtsecuritiesamortizedcostbasis": 4478000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 31000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "availableforsalesecuritiesdebtsecurities": 4478000,
    "interestreceivablecurrent": 400000,
    "numberofoptionperiodforfundingfromgovernmentcontract": "P31M",
    "governmentcontractincomerecognized": 900000,
    "governmentcontractreceivedduringyear": 500000,
    "governmentcontractreceivable": 400000,
    "fundingofoptionextendsestimatedcompletionofcontractterm": "P13M",
    "proceedsfromgovernmentcontract": 5000000,
    "contractterm": "P18M",
    "grantsreceivable": 600000,
    "grantincomerecognized": 1300000,
    "lesseeoperatingleaseoptiontoextend": "lease was amended to extend the term to expire in August 2022",
    "operatingleaseexpirationdate": "2022-08",
    "lesseeoperatingleaserenewalterm": "P12M",
    "operatingleaserenewalperiod": "2025-08",
    "operatingleasepayments": 50000,
    "operatingleasecost": 54000,
    "shorttermleasecost": 107000,
    "leasecost": 161000,
    "accruedresearchanddevelopmentrelatedexpensescurrent": 6555000,
    "accruedprofessionalservicesexpenses": 24000,
    "otheraccruedliabilitiescurrent": 102000,
    "longtermpurchasecommitmentperiod": "P10Y",
    "proceedsfrominvestment": 2500000,
    "commonstockvotingrights": "one",
    "commonstockcapitalsharesreservedforfutureissuance": 3930306,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 4423920,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1254721,
    "percentageofannualincreaseinsharesreservedforfutureissuanceoncommonstockoutstanding": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P36M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofshares": 561000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreasepercentageofcommonstockoutstanding": 0.01,
    "allocatedsharebasedcompensationexpense": 4236000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.53,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 18000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M12D",
    "sharebasedpaymentarrangementunvestedsharesoutstandingissueduponearlyexerciseofstockoptions": 5040,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardrequisiteserviceperiod1": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The right to repurchase these shares generally lapses with respect to 25% of the shares underlying the option after one year of service to the Company and 1/48th of the shares underlying the original grant per month for 36 months thereafter.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.908,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0404,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3930306,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1224932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 75867,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1847955,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.48,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 11.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 9.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y6M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 37853000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 20612000,
    "valuationallowancedeferredtaxassetchangeinamount": 20000000,
    "operatinglosscarryforwards": 58200000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 3400000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "unrecognizedtaxbenefits": 1500000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -13593000,
    "incometaxreconciliationstateandlocalincometaxes": -4917000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 20047000,
    "incometaxreconciliationtaxcreditsresearch": 2030000,
    "incometaxreconciliationotheradjustments": 493000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.007,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.076,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.031,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.31,
    "deferredtaxassetsoperatinglosscarryforwards": 20778000,
    "deferredtaxassetscapitalresearchexpenditures": 14014000,
    "deferredtaxassetstaxcreditcarryforwards": 4406000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2568000,
    "deferredtaxassetsother": 52000,
    "deferredtaxassetsgross": 41818000,
    "deferredtaxassetsvaluationallowance": 41818000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 678000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3930306
  },
  {
    "date": "2022-12-30",
    "symbol": "ANTX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": " December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "December 31",
    "entityregistrantname": "AN2 Therapeutics, Inc.",
    "entitycentralindexkey": 1880438,
    "entityfilenumber": "001-41331",
    "entitytaxidentificationnumber": "82-0606654",
    "entityincorporationstatecountrycode": "Delaware",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "true",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "1800 El Camino Real",
    "entityaddressaddressline2": "Suite D",
    "entityaddresscityortown": "Menlo Park",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94027,
    "cityareacode": 650,
    "localphonenumber": "331-9090",
    "security12btitle": "Common Stock",
    "tradingsymbol": "ANTX",
    "securityexchangename": "The Nasdaq Global Select Market",
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "San Jose, California",
    "auditorfirmid": 238,
    "cashandcashequivalentsatcarryingvalue": 27219000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 68840000,
    "prepaidexpenseandotherassetscurrent": 2509000,
    "operatingleaserightofuseassetcurrent": 53000,
    "assetscurrent": 98621000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 3219000,
    "otherassetsnoncurrent": 720000,
    "assets": 102560000,
    "accountspayablecurrent": 2122000,
    "employeerelatedliabilitiescurrent": 2168000,
    "accruedliabilitiescurrent": 2837000,
    "operatingleaseliabilitycurrent": 53000,
    "optionssubjecttorepurchaseshortterm": 6000,
    "liabilitiescurrent": 7186000,
    "optionssubjecttorepurchaselongterm": 2000,
    "liabilities": 7188000,
    "additionalpaidincapital": 185469000,
    "accumulatedothercomprehensiveincomelossnetoftax": -374000,
    "retainedearningsaccumulateddeficit": 89700000,
    "stockholdersequity": -89723000,
    "liabilitiesandstockholdersequity": 102560000,
    "temporaryequityparorstatedvaluepershare": 0.00001,
    "preferredstockparorstatedvaluepershare": 0.00001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.00001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 28511000,
    "researchanddevelopmentrelatedparty": 1000000,
    "generalandadministrativeexpense": 12751000,
    "operatingexpenses": 42262000,
    "operatingincomeloss": -42262000,
    "investmentincomenet": 1351000,
    "othernonoperatingincomeexpense": -45000,
    "netincomeloss": 41000000,
    "preferredstockdividendsandotheradjustments": 1820000,
    "netincomelossavailabletocommonstockholdersbasic": -42776000,
    "earningspersharebasic": -2.79,
    "earningspersharediluted": -2.79,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -347000,
    "comprehensiveincomenetoftax": -41303000,
    "temporaryequityconversionofconvertiblepreferredstockintocommonstockvalue": 111139000,
    "temporaryequityconversionofconvertiblepreferredstockintocommonstockshares": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluenewissues": 9530000,
    "stockissuedduringperiodsharesnewissues": 690000,
    "vestingofearlyexercisedstockoptions": 21000,
    "repurchaseofearlyexercisedstockoption": 11000,
    "repurchaseofearlyexercisedstockoptionsshares": 27128,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4391000,
    "temporaryequityaccretiontoredemptionvalueandcumulativedividendsonpreferredstock": 1820000,
    "accretionordecreasetoredemptionvalueandcumulativedividendsonpreferredstock": -1820000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 111139000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -347000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 800000,
    "profitloss": -40956000,
    "sharebasedcompensation": 4391000,
    "noncashoperatingleaseexpense": 77000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 692000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 958000,
    "increasedecreaseinotheroperatingassets": 720000,
    "increasedecreaseinaccountspayable": 2497000,
    "increasedecreaseinaccruedcompensation": 1252000,
    "increasedecreaseinaccruedliabilities": 1724000,
    "increasedecreaseinoperatingleaseliability": -77000,
    "netcashprovidedbyusedinoperatingactivities": 33500000,
    "paymentstoacquireinvestments": 93836000,
    "proceedsfromsalematurityandcollectionsofinvestments": 72065000,
    "netcashprovidedbyusedininvestingactivities": -21771000,
    "proceedsfromissuanceinitialpublicoffering": 70366000,
    "repurchaseofearlyexercisedstockoptions": 11000,
    "netcashprovidedbyusedinfinancingactivities": 70355000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 15122000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 27219000,
    "conversionofstockamountconverted1": 111139000,
    "accretiontoredemptionvalueandcumulativedividendsonpreferredstock": 1820000,
    "cashcashequivalentsandshortterminvestments": 99300000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "stockholdersequitynotestocksplit": "shares of common stock and then existing redeemable convertible preferred stock and per share amounts have been adjusted on a retroactive basis to reflect our 2.352936-for-1 forward stock split",
    "investments": 72100000,
    "debtsecuritiesavailableforsaleunrealizedgainloss": -300000,
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2022",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "operatingleaseliability": 53000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 82585000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 6000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 380000,
    "availableforsalesecuritiesdebtsecurities": 82211000,
    "proceedsfromgovernmentcontract": 4300000,
    "contractterm": 18,
    "researchanddevelopmentexpenserelatedparty": 1000000,
    "lesseeoperatingleaseoptiontoextend": "lease was amended to extend the term to expire in August 2022",
    "operatingleaseexpirationdate": "August 2022",
    "lesseeoperatingleaserenewalterm": "12-month",
    "operatingleaserenewalperiod": "August 2025",
    "operatingleasepayments": 80000,
    "operatingleaseweightedaverageremainingleaseterm1": 0.67,
    "operatingleaseweightedaveragediscountratepercent": 0.051,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 54000,
    "lesseeoperatingleaseliabilitypaymentsdue": 54000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1000,
    "operatingleasecost": 80000,
    "shorttermleasecost": 72000,
    "leasecost": 152000,
    "accruedresearchanddevelopmentrelatedexpensescurrent": 2517000,
    "accruedprofessionalservicesexpenses": 198000,
    "otheraccruedliabilitiescurrent": 122000,
    "longtermpurchasecommitmentperiod": "ten years",
    "proceedsfromissuanceofcommonstock": 2500000,
    "proceedsfrominvestment": 2500000,
    "commonstockcapitalsharesreservedforfutureissuance": 187000,
    "commonstockvotingrights": "one",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 187000,
    "percentageofannualincreaseinsharesreservedforfutureissuanceoncommonstockoutstanding": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddurationofannualincreaseincommonstockreservedforfutureissuance": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumemployeesubscriptionrate": 0.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreaseinnumberofshares": 561000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardincreasepercentageofcommonstockoutstanding": 0.01,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.03,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 15000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.8,
    "sharebasedpaymentarrangementunvestedsharesoutstandingissueduponearlyexerciseofstockoptions": 19778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "The right to repurchase these shares generally lapses with respect to 25% of the shares underlying the option after one year of service to the Company and 1/48th of the shares underlying the original grant per month for 36 months thereafter.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8340000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.030699999999999998,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 31832,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 987857,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.13,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 15.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 8.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5793000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3865000,
    "valuationallowancedeferredtaxassetchangeinamount": 12300000,
    "operatinglosscarryforwards": 66300000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "taxcreditcarryforwardamount": 600000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "unrecognizedtaxbenefits": 800000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8601000,
    "incometaxreconciliationstateandlocalincometaxes": -3053000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 12347000,
    "incometaxreconciliationtaxcreditsresearch": 988000,
    "incometaxreconciliationotheradjustments": 295000,
    "deferredtaxassetsoperatinglosscarryforwards": 13709000,
    "deferredtaxassetsgoodwillandintangibleassets": 5337000,
    "deferredtaxassetstaxcreditcarryforwards": 1836000,
    "deferredtaxassetsother": 889000,
    "deferredtaxassetsgross": 21771000,
    "deferredtaxassetsvaluationallowance": 21771000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 338000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 1500000
  }
]